ORGANOGENESIS HOLDINGS INC
NASDAQ: ORGO (Organogenesis Holdings Inc.)
Kemas kini terakhir: 1 jam lalu4.74
-0.18 (-3.66%)
| Penutupan Terdahulu | 4.92 |
| Buka | 4.94 |
| Jumlah Dagangan | 729,617 |
| Purata Dagangan (3B) | 1,537,063 |
| Modal Pasaran | 601,563,520 |
| Harga / Jualan (P/S) | 1.37 |
| Harga / Buku (P/B) | 2.48 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 6 Nov 2025 |
| Margin Keuntungan | -3.46% |
| Margin Operasi (TTM) | -23.28% |
| EPS Cair (TTM) | -0.160 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -21.20% |
| Pertumbuhan Pendapatan Suku Tahunan (YOY) | 289.40% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 11.58% |
| Nisbah Semasa (MRQ) | 4.12 |
| Aliran Tunai Operasi (OCF TTM) | 4.43 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -4.36 M |
| Pulangan Atas Aset (ROA TTM) | 0.70% |
| Pulangan Atas Ekuiti (ROE TTM) | -4.92% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Drug Manufacturers - Specialty & Generic (US) | Menaik | Bercampur |
| Drug Manufacturers - Specialty & Generic (Global) | Menaik | Bercampur | |
| Stok | Organogenesis Holdings Inc. | Menaik | Menaik |
AISkor Stockmoo
| Konsensus Penganalisis | 3.5 |
| Aktiviti Orang Dalam | -3.5 |
| Volatiliti Harga | -1.0 |
| Purata Bergerak Teknikal | -1.0 |
| Osilator Teknikal | -0.5 |
| Purata | -0.50 |
|
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced wound care, surgical and sports medicine markets. Its product category includes Advanced Wound Care and Surgical and Sports Medicine. It has single operating segment which has regenerative medicine. The company generates maximum revenue from Advanced Wound Care products. Some of its products include PuraPly Antimicrobial, Affinity, NuShield, Apligraf, Dermagraft and others. |
|
| Sektor | Healthcare |
| Industri | Drug Manufacturers - Specialty & Generic |
| Gaya Pelaburan | Small Core |
| % Dimiliki oleh Orang Dalam | 46.49% |
| % Dimiliki oleh Institusi | 54.09% |
| Julat 52 Minggu | ||
| Median | 9.00 (89.87%) | |
| Jumlah | 1 Beli | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| BTIG | 20 Nov 2025 | 9.00 (89.87%) | Beli | 5.12 |
| 26 Sep 2025 | 7.00 (47.68%) | Beli | 4.10 |
| Nama | Purata Belian ($) | Purata Jualan ($) | Jumlah Net | Jumlah Nilai Bersih ($) |
|---|---|---|---|---|
| NUSSDORF GLENN H | - | 5.36 | -300,000 | -1,621,314 |
| Jumlah Keseluruhan Kuantiti Bersih | -300,000 | |||
| Jumlah Keseluruhan Nilai Bersih ($) | -1,621,314 | |||
| Purata Pembelian Keseluruhan ($) | - | |||
| Purata Jualan Keseluruhan ($) | 5.36 | |||
| Nama | Pemegang | Tarikh | Jenis | Kuantiti | Harga | Nilai ($) |
|---|---|---|---|---|---|---|
| NUSSDORF GLENN H | Pengarah | 26 Nov 2025 | Jual (-) | 187,957 | 5.42 | 1,018,727 |
| NUSSDORF GLENN H | Pengarah | 25 Nov 2025 | Jual (-) | 12,043 | 5.28 | 63,587 |
| NUSSDORF GLENN H | Pengarah | 24 Nov 2025 | Jual (-) | 100,000 | 5.39 | 539,000 |
| Tarikh | Jenis | Butiran |
|---|---|---|
| 06 Nov 2025 | Pengumuman | Organogenesis Holdings Inc. Reports Third Quarter 2025 Financial Results, Posts Record Revenue and Raises 2025 Guidance |
| 03 Nov 2025 | Pengumuman | Organogenesis Applauds CMS’s Significant Step In Payment Reform |
| 31 Oct 2025 | Pengumuman | Organogenesis Holdings Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) |
| 01 Oct 2025 | Pengumuman | Organogenesis Holdings Inc. to Report Third Quarter of Fiscal Year 2025 Financial Results on November 6, 2025 |
| 25 Sep 2025 | Pengumuman | Organogenesis Provides Update on Second Phase 3 ReNu® Study |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |